DePuy Synthes Inc. - Strategic SWOT Insights
| 出版社 | Quaintel Research |
| 出版年月 | 2025年6月 |
| ページ数 | 110 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | 150 |
| 種別 | 英文調査報告書 |
Report Overview
Report Summary
DePuy Synthes Inc. – Strategic SWOT Insights – A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI’s, and Recent Trends is a comprehensive and easily accessible overview of DePuy Synthes Inc. ‘s business operations. It provides a detailed analysis of the company’s strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company’s performance.
The report begins with in-depth information about DePuy Synthes Inc. including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company’s key attributes.
Next, the report assesses DePuy Synthes Inc.’s strategic standing through various analyses. The ESG spotlight evaluates the company’s environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company’s internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of DePuy Synthes Inc.’s overall strategic standing and supports informed decision-making and strategic planning.
Finally, the report includes recent news and deal activities undertaken by DePuy Synthes Inc. enhancing awareness of the company’s business trends, growth perspectives, and more.
Key Highlights
DePuy Synthes Inc., founded in 1895, the company is headquartered in United States operates as a subsidiary of Johnson and Johnson that designs and manufactures orthopedic and neurological devices and supplies for healthcare professionals, patients, and caregivers worldwide. DePuy Synthes Inc. operates in the segments of joint reconstruction, trauma, craniomaxillofacial and thoracic, spine, sports medicine, neuroscience, surgical solutions and orthopedic care.
DePuy Synthes Inc. offers a range of products and services including joint reconstruction solutions for hip, knee and shoulder replacement; trauma devices for internal and external fixation; implants and instruments for surgical treatment of fractures, deformities and tumor diseases of long bones; spinal care solutions for thoracolumbar, cervical and aging spine issues; pain management and minimally invasive solutions; diagnostic and therapeutic products for neurological and neurovascular disorders; biomaterials for trauma, spine and maxillofacial surgery; fenestrated screw systems for spinal fusion surgery; printed implants for facial reconstruction; and animal orthopedic products.
DePuy Synthes Inc. in the News:-
– 10-Mar-2025 – Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025
– 14-Nov-2024 – Johnson & Johnson MedTech Announces Strategic Agreement with Responsive Arthroscopy to Expand Sports Soft Tissue Solutions
– 10-Oct-2024 – Johnson & Johnson MedTech Launches VOLT Plating System
Scope
• Tactical Analysis:- Various strategic frameworks to gain insights into a DePuy Synthes Inc.’s competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the DePuy Synthes Inc.’s overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Company Fundamentals:- These fundamentals offer valuable insights into the DePuy Synthes Inc.’s history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the DePuy Synthes Inc.’s main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
• Comprehensive Understanding of the DePuy Synthes Inc.’s internal and external factors through SWOT analysis and Corporate Strategy.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company DePuy Synthes Inc.:
• DePuy Synthes Inc. PESTLE Analysis
• DePuy Synthes Inc. Value Chain Analysis
• DePuy Synthes Inc. Porter’s Five Forces Analysis
• DePuy Synthes Inc. VRIO Analysis
• DePuy Synthes Inc. BCG Analysis
• DePuy Synthes Inc. Segmentation, Targeting and Positioning (STP) Analysis
• DePuy Synthes Inc. Ansoff Matrix Analysis
Table of Contents
Table of Contents
Table of Contents 2
Tables 5
Charts 6
DePuy Synthes Inc. – Key Company Facts 7
DePuy Synthes Inc. – Company Description 8
DePuy Synthes Inc. – Top Executives 9
DePuy Synthes Inc. – Top Executives Biographies 10
DePuy Synthes Inc. – Head Office & Locations 15
Head Office – Country 15
Key Subsidiaries 16
DePuy Synthes Inc. – Products and Services 17
Products 17
Services 18
DePuy Synthes Inc. – Historic Events 19
DePuy Synthes Inc. – Company’s Mission and Vision 21
Mission 21
Vision 21
DePuy Synthes Inc. – Corporate Strategy 22
DePuy Synthes Inc. – Business Description 26
Trauma & Extremities 26
Advanced Surgical Technologies 27
Sports Medicine & Shoulder Reconstruction 27
Spinal Care 28
Orthopaedics 28
DePuy Synthes Inc. – ESG Spotlight 30
Environment 30
Social 31
Corporate Governance 31
DePuy Synthes Inc. – SWOT Analysis 33
Overview 33
Strengths 35
Weaknesses 37
Opportunities 38
Threats 40
Competing Players 41
Snapshot of Competing Players 42
CONMED Corporation 42
Key Company Facts 42
Company Description 42
Key Financials 43
Share Price Trend – Jan-2024 to Jun-2025 (Average Share Closing Price) 43
Key Financial Ratio Analysis 48
Smith & Nephew Plc 49
Key Company Facts 49
Company Description 49
Smith & Nephew Plc – SWOT Spotlight 50
Smith & Nephew Plc – PESTLE Spotlight 52
Key Financials 54
Share Price Trend – Jan-2024 to Jun-2025 (Average Share Closing Price) 54
Key Financial Ratio Analysis 59
Stryker Corporation 60
Key Company Facts 60
Company Description 60
Stryker Corporation – SWOT Spotlight 61
Stryker Corporation – PESTLE Spotlight 63
Key Financials 65
Share Price Trend – Jan-2024 to Jun-2025 (Average Share Closing Price) 65
Key Financial Ratio Analysis 70
Zimmer Biomet Holdings Inc 71
Key Company Facts 71
Company Description 71
Zimmer Biomet Holdings Inc – SWOT Spotlight 72
Zimmer Biomet Holdings Inc – PESTLE Spotlight 74
Key Financials 76
Share Price Trend – May-2024 to Jun-2025 (Average Share Closing Price) 76
Key Financial Ratio Analysis 81
Arthrex Inc 82
Key Company Facts 82
Company Description 82
DePuy Synthes Inc. – In the News 83
10-Mar-2025- Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025 83
10-Mar-2025- Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025 85
14-Nov-2024- Johnson & Johnson MedTech Announces Strategic Agreement with Responsive Arthroscopy to Expand Sports Soft Tissue Solutions 87
10-Oct-2024- Johnson & Johnson MedTech Launches VOLT Plating System 88
09-Oct-2024- Johnson & Johnson MedTech Launches VOLT Plating System 88
29-Aug-2024- DePuy Synthes Launches MatrixSTERNUM Fixation System for Enhanced Chest Stability Following Cardiac Surgery 91
08-Aug-2024- DePuy Synthes Launches TriLEAP Lower Extremity Anatomic Plating System 93
02-Aug-2024- DePuy Synthes Launches its First Active Spine Robotics and Navigation Platform 95
06-Jun-2024- DePuy Synthes Receives 510(k) FDA Clearance of the VELYS™ Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures 97
08-Apr-2024- DePuy Synthes to showcase latest innovations across comprehensive spine portfolio at IMAST 2024 99
DePuy Synthes Inc. – Key Deals 101
14-Nov-2024 – Johnson & Johnson MedTech Announces Strategic Agreement with Responsive Arthroscopy to Expand Sports Soft Tissue Solutions 101
21-Mar-2022 – DePuy Synthes Acquires CUPTIMIZE™ Hip-Spine Analysis, Providing Technology to Help Surgeons Better Understand, Measure and Address Pelvic Tilt 102
10-Feb-2022 – DePuy Synthes Acquires CrossRoads® Extremity Systems 103
01-Dec-2021 – DePuy Synthes Announces Acquisition of OrthoSpin 105
14-May-2018 – DePuy Synthes Signs Definitive Agreement to Acquire Assets of Medical Enterprises Distribution, LLC to Strengthen its Portfolio and Amplify the Surgeon’s Capabilities Via Automation 106
Appendix 107
Definitions 107
SWOT Analysis 107
PESTLE Analysis 107
Value Chain Analysis 107
ESG Spotlight 107
Research Methodology 108
Disclaimer 109
Contact Us 109
Tables
Table 1: DePuy Synthes Inc. – Company Facts
Table 2: DePuy Synthes Inc. – Digital Presence
Table 3: DePuy Synthes Inc. – Top Executives
Table 4: DePuy Synthes Inc. – Top Executives Biographies
Table 5: DePuy Synthes Inc. – Subsidiaries
Table 6: DePuy Synthes Inc. – Products
Table 7: DePuy Synthes Inc. – Services
Table 8: DePuy Synthes Inc. – Historic Events
Table 9: DePuy Synthes Inc. -Competing Players
Table 10: Competing Players – CONMED Corporation – Key Company Facts
Table 11: CONMED Corporation – Share Price Trend – Jan-2024 to Jun-2025
Table 12: Competing Players – CONMED Corporation – Profit and Loss Statement
Table 13: CONMED Corporation – Balance Sheet 2021-2024
Table 14: CONMED Corporation – Cash Flow Statement 2021-2024
Table 15: CONMED Corporation – Ratio Analysis – 2020-2023
Table 16: Competing Players – Smith & Nephew Plc – Key Company Facts
Table 17: Smith & Nephew Plc – Share Price Trend – Jan-2024 to Jun-2025
Table 18: Competing Players – Smith & Nephew Plc – Profit and Loss Statement
Table 19: Smith & Nephew Plc – Balance Sheet 2021-2024
Table 20: Smith & Nephew Plc – Cash Flow Statement 2021-2024
Table 21: Smith & Nephew Plc – Ratio Analysis – 2020-2023
Table 22: Competing Players – Stryker Corporation – Key Company Facts
Table 23: Stryker Corporation – Share Price Trend – Jan-2024 to Jun-2025
Table 24: Competing Players – Stryker Corporation – Profit and Loss Statement
Table 25: Stryker Corporation – Balance Sheet 2021-2024
Table 26: Stryker Corporation – Cash Flow Statement 2021-2024
Table 27: Stryker Corporation – Ratio Analysis – 2020-2023
Table 28: Competing Players – Zimmer Biomet Holdings Inc – Key Company Facts
Table 29: Zimmer Biomet Holdings Inc – Share Price Trend – May-2024 to Jun-2025
Table 30: Competing Players – Zimmer Biomet Holdings Inc – Profit and Loss Statement
Table 31: Zimmer Biomet Holdings Inc – Balance Sheet 2021-2024
Table 32: Zimmer Biomet Holdings Inc – Cash Flow Statement 2021-2024
Table 33: Zimmer Biomet Holdings Inc – Ratio Analysis – 2020-2023
Table 34: Competing Players – Arthrex Inc – Key Company Facts
Charts
Figure 1: DePuy Synthes Inc. – SWOT Analysis
Figure 2: CONMED Corporation – Average Share Price Trend -Jan-2024 to Jun-2025
Figure 3: CONMED Corporation – Profit and Loss Statement – 2021-2024
Figure 4: CONMED Corporation – Balance Sheet – 2021-2024
Figure 5: CONMED Corporation – Cash Flow Statement 2021-2024
Figure 6: Competing Players – Smith & Nephew Plc – SWOTSpotlight
Figure 7: Competing Players – Smith & Nephew Plc – PESTLE Spotlight
Figure 8: Smith & Nephew Plc – Average Share Price Trend -Jan-2024 to Jun-2025
Figure 9: Smith & Nephew Plc – Profit and Loss Statement – 2021-2024
Figure 10: Smith & Nephew Plc – Balance Sheet – 2021-2024
Figure 11: Smith & Nephew Plc – Cash Flow Statement 2021-2024
Figure 12: Competing Players – Stryker Corporation – SWOTSpotlight
Figure 13: Competing Players – Stryker Corporation – PESTLE Spotlight
Figure 14: Stryker Corporation – Average Share Price Trend -Jan-2024 to Jun-2025
Figure 15: Stryker Corporation – Profit and Loss Statement – 2021-2024
Figure 16: Stryker Corporation – Balance Sheet – 2021-2024
Figure 17: Stryker Corporation – Cash Flow Statement 2021-2024
Figure 18: Competing Players – Zimmer Biomet Holdings Inc – SWOTSpotlight
Figure 19: Competing Players – Zimmer Biomet Holdings Inc – PESTLE Spotlight
Figure 20: Zimmer Biomet Holdings Inc – Average Share Price Trend -May-2024 to Jun-2025
Figure 21: Zimmer Biomet Holdings Inc – Profit and Loss Statement – 2021-2024
Figure 22: Zimmer Biomet Holdings Inc – Balance Sheet – 2021-2024
Figure 23: Zimmer Biomet Holdings Inc – Cash Flow Statement 2021-2024
Quaintel Research(クアインテルリサーチ)は200セクター超における世界の企業の競合ベンチマーキング、販売情報、投資魅力度、イノベーションについてデータ駆動型の実用的な情報を提供する専門調査会社です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | エンタープライズ |
| USD 150 | USD 175 | USD 195 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨(定価)を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。手数料(ハンドリングチャージ)無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業同一住所内人数無制限でレポートファイルのご共有が可能です。
- エンタープライズライセンス
- 同一企業であれば、人数無制限でレポートファイルの閲ご共有が可能です。
- シングルユーザライセンス
- 納期
- ご注文後2-3営業日以内
- 納品形態
- Eメール
注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでのご注文をお待ちしております。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
最新調査レポート
- Benteler International AGの戦略的SWOTインサイト 2025-04-30
- Schauinsland-Reisen GmbHの戦略的SWOTインサイト 2025-04-30
- Seat, S.A.の戦略的SWOTインサイト 2025-04-30
- Havas N.A.の戦略的SWOTインサイト 2025-04-30
- TelevisaUnivision Incの戦略的SWOTインサイト 2025-04-30
Quaintel Research出版の市場調査レポートに関するご質問やサンプルページのご依頼等はいつでもお気軽にお問合せください。